TCA
BMY icon

Taconic Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Taconic Capital Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-450,000
Closed -$21.5M – 48
2019
Q1 		$21.5M Buy
+450,000
New +$22.4M 1.21% 21
2017
Q2 		– Sell
-100,000
Closed -$72K – 32
2017
Q1 		$72K Buy
+100,000
New +$5.48M 0.01% 28

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Taconic Capital Advisors's BMY Position: Q4 2017 in Review

Taconic Capital Advisors sold out of Bristol-Myers Squibb (BMY) in Q4 2017, closing a stake of 35,000 shares — an estimated $2.23M sold.

Taconic Capital Advisors first reported a position in BMY in Q1 2017 and held it in 3 quarters. The position peaked at $2.79M in Q2 2017. 1,735 funds tracked by Wall St. Rank hold BMY as of Q4 2017.

  • Taconic Capital Advisors reported no remaining Bristol-Myers Squibb position as of Q4 2017 after selling out during the quarter.
  • Taconic Capital Advisors sold 35,000 Bristol-Myers Squibb shares in Q4 2017, an estimated $2.23M.
  • Taconic Capital Advisors first reported a position in Bristol-Myers Squibb in Q1 2017 and held it in 3 quarters.
  • Taconic Capital Advisors's Bristol-Myers Squibb position peaked at $2.79M in Q2 2017.
  • 1,735 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2017.

Based on Taconic Capital Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.